20 casesAmong 250 patients with HIV/AIDS screened for HBV, 20 (8%) were identified as HBV-infected.
Nigeriahépatite B · VIH/sidapublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 11 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 729 evidences · page 39 / 70
20 casesAmong 250 patients with HIV/AIDS screened for HBV, 20 (8%) were identified as HBV-infected.
Nigeriahépatite B · VIH/sidapublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 11 observations
4,9 odds_ratioThe adjusted odds ratio for finding an HIV-positive child at the pediatric inpatient ward compared with the POPD was 4.9 (95% CI: 1.9–12.8).
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 16 observations
66,7 %In this study, 66.7% of the 117 youth living with HIV/AIDS in Lagos State reported fear of HIV disclosure as a barrier to service utilisation.
NigeriaVIH/sidaobservé 2022publié 2025African journal of reproductive healthPubMeddocument de 7 observations
68,6 %Among 229 HIV-1 positive individuals, 68.6% were ART-experienced.
NigeriaVIH/sidaobservé May 2023 to August 2024publié 2025AIDS research and therapyPubMeddocument de 7 observations
35,8 %The prevalence of disclosure of HIV status to children living with HIV was 35.8% in Gombe, northeast Nigeria.
NigeriaVIH/sidapublié 2020BMC public healthPubMeddocument de 5 observations
1,17 aORAdolescents and young adults in the 'consent and proximity' class were more likely to report engaging in intergenerational sex (adjusted odds ratio 1.17, 95% confidence interval 1.02–1.35).
NigeriaVIH/sidaobservé 2018publié 2024PloS onePubMeddocument de 15 observations
94,6 %Of 662 patients with a follow-up viral load after virologic failure on tenofovir, lamivudine, and dolutegravir (TLD), 94.6% remained on TLD.
NigeriaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 8 observations
75 %75% of respondents were willing to pay an average fee of N1 291 ($4.22) for HIV counselling and testing services.
NigeriaVIH/sidapublié 2020African journal of AIDS research : AJARPubMeddocument de 3 observations
47,1 %Among 17 HIV-infected, HIV-exposed infants in Plateau State, Nigeria who experienced treatment mortality or losses (TX_ML), 47.1% (8/17) died.
NigeriaVIH/sidaobservé 2018–2022publié 2026PloS onePubMeddocument de 13 observations
3 200 000 peopleIn Nigeria, an estimated 3.2 million people were living with HIV.
NigeriaVIH/sidapublié 2016PloS onePubMeddocument de 14 observations
72,3 %72.3% of respondents in the control group still had poor HIV/AIDS knowledge post-test.
NigeriaVIH/sidapublié 2024BMC public healthPubMeddocument de 5 observations
85,9 %Retention in care at 12 months was 85.9% for point-of-care monitoring and 76.9% for standard-of-care monitoring in per-protocol analysis.
NigeriaVIH/sidaobservé 12 monthspublié 2023Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 5 observations
0,6 %One participant (0.6%) had suicidal ideation among people living with HIV in two rural secondary health facilities in Southwestern Nigeria between September and December 2020.
NigeriaVIH/sidaobservé September and December 2020publié 2023AIDS research and therapyPubMeddocument de 8 observations
41,2 %Among HIV seropositive pregnant women in Port Harcourt, Nigeria, 41.2% were in the age group of 31–42 years.
NigeriaVIH/sidapublié 2020Journal of immunoassay & immunochemistryPubMeddocument de 6 observations
59,3 %Majority of participants were unaware of their spouses' HIV status (59.3%).
NigeriaVIH/sidapublié 2019The Pan African medical journalPubMeddocument de 5 observations
83,4 %Retention in HIV treatment was 83.4% among control group participants at endline.
NigeriaVIH/sidapublié 2020Journal of medical Internet researchPubMeddocument de 5 observations
0,2 %HIV-2 accounted for 0.2% of confirmed HIV-positive cases in the Nigeria AIDS Indicator and Impact Survey (NAIIS) 2018.
NigeriaVIH/sidaobservé 2018publié 2022PLOS global public healtheurope_pmcdocument de 10 observations
3,2 %Among 324 youth in Nigeria recruited between September 2019 and March 2020, 3.2% reported having used pre-exposure prophylaxis.
NigeriaVIH/sidaobservé September 2019 to March 2020publié 2024BMC health services researchPubMeddocument de 7 observations
200 copies/mLThe primary endpoint was viral suppression defined as HIV-1 RNA <200 copies/mL.
NigeriaVIH/sidapublié 2025Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 7 observations
2,7 correct_responsesAmong 534 participants who completed all three HIV-related knowledge assessments, the mean number of correct responses rose from 2.70 to 3.02 and then to 3.06.
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 6 observations
68,4 %68.4% of the respondents accessed HIV Counselling and Testing (HCT) in the index pregnancy.
NigeriaVIH/sidapublié 2021West African journal of medicinePubMeddocument de 4 observations
303,08 cells/µlThe CD4+ count among HIV-infected patients in Port Harcourt ranged from 22 to 864 cells/µl with a mean value of 303.08.
NigeriaVIH/sidapublié 2021African health sciencesPubMeddocument de 4 observations
31,8 %Almost a third (31.8%) of the study subjects receiving HIV treatment in private facilities in the Federal Capital Territory, Benue, and Nasarawa states in north-central Nigeria had received antiretroviral treatment (ART) for less than a year at censoring.
NigeriaVIH/sidaobservé 2013–2019publié 2022AIDS research and therapyPubMeddocument de 3 observations
18 600 NairaThe mean willingness-to-pay (WTP) for services involving primary prevention of HIV was N18,600.
NigeriaVIH/sidapublié 2019Value in health regional issuesPubMeddocument de 4 observations
50 %The number of children newly infected with HIV dropped by 50%, from 320000 in 2010 to 160000 in 2021.
NigeriaVIH/sidaobservé 2010 to 2021publié 2023Journal of the International Association of Providers of AIDS CarePubMeddocument de 3 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.